Novo Nordisk Pharmatech A/S: Financial statements 2018
CVR: 13246149
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Novo Nordisk Pharmatech A/S (CVR 13246149) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 690,700,000 and a net result of DKK 105,268,000 compared with DKK 103,665,000 the year before. That is an increase of 11% compared with the year before. The profit margin was 15.2%. Equity in the 2018 report amounted to DKK 614,221,000. The solvency ratio was 80.7%. The company had 170 employees in the financial year.
- Revenue
- DKK 690,700,000
- Gross Profit
- DKK 283,278,000
- Profit/Loss
- DKK 105,268,000
- Equity
- DKK 614,221,000
- Total Assets
- DKK 760,808,000
- Employees
- 170
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 690.7M | 283.3M | 105.3M | 614.2M | 170 |
| 2017 | 622.4M | 263.4M | 103.7M | 529M | 163 |
| 2016 | 669.1M | 238M | 87.4M | 468.3M | 158 |
| 2015 | 505.2M | 228M | 92.1M | 400.9M | 150 |
| 2014 | 495.2M | 176.6M | 55.3M | 336.8M | 150 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of November 1, 2018, Søren Thor Jensen has joined the board of directors of Novo Nordisk Pharmatech A/S.
As of November 1, 2018, Ole Falvig Ramsby has left the board of directors of Novo Nordisk Pharmatech A/S.
As of June 30, 2018, Lars Sørensen has left the board of directors of Novo Nordisk Pharmatech A/S.
Novo Nordisk Pharmatech A/S has published its annual report for 2017. Revenue came to DKK 622,436,000, and the net result was DKK 103,665,000.
About Novo Nordisk Pharmatech A/S
Novo Nordisk Pharmatech A/S is a Danish company of the type Aktieselskab based in Køge, founded in 1989. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named FEF CHEMICALS A/S and FERROSAN FINE CHEMICALS A/S. The management consists of Ulla Grove Krogsgaard Thomsen. The board consists of Mette Sofie Mørck Jarl (chair), Christian Brøgger Stolberg, Jacob Sten Petersen and Joachim Juel Hagemeister. The company is owned by NOVO NORDISK A/S. The company has 489 employees (2026). In 2025, the company reported revenue of DKK 1,041,584,000 and a net result of DKK 113,891,000 compared with DKK 60,619,000 the year before. Equity in the 2025 report amounted to DKK 2,441,318,000.
